Author

Srinivas Kantham

Institution: Simon Fraser University

Observed institutions: The University of Queensland, Simon Fraser University

ORCID: 0000-0002-3847-2025

Observed ORCID: 0000-0002-3847-2025

OpenAlex ID: A5070123212

Metal chelation, radical scavenging and inhibition of Aβ42 fibrillation by food constituents in relation to Alzheimer’s disease

2015 · Stephen Chan, Srinivas Kantham, et al. · Food Chemistry · 113

E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis

2021 · Jay V. Patankar, Tanja M. Müller, et al. · Nature Cell Biology · 70

Multifunctional Analogs of Kynurenic Acid for the Treatment of Alzheimer’s Disease: Synthesis, Pharmacology, and Molecular Modeling Studies

2017 · Girdhar Singh Deora, Srinivas Kantham, et al. · ACS Chemical Neuroscience · 45

Effect of the Biphenyl Neolignan Honokiol on Aβ42-Induced Toxicity in Caenorhabditis elegans, Aβ42 Fibrillation, Cholinesterase Activity, DPPH Radicals, and Iron(II) Chelation

2017 · Srinivas Kantham, Stephen Chan, et al. · ACS Chemical Neuroscience · 45

Rivastigmine and metabolite analogues with putative Alzheimer’s disease-modifying properties in a Caenorhabditis elegans model

2019 · Satish N. Dighe, Eugenio De la Mora, et al. · Communications Chemistry · 38

Design, Synthesis, Pharmacokinetics, and Biodistribution of a Series of Bone-Targeting EP4 Receptor Agonist Prodrugs for Treatment of Osteoporosis and Other Bone Conditions

2021 · Marion Thévenin, Gang Chen, et al. · ACS Pharmacology & Translational Science · 7

Synthesis of some new (1,3,4)oxadiazine-(6,5-b)indole derivatives and their biological activity

2014 · Tumma Soujanya, Srinivas Kantham · African Journal of Pharmacy and Pharmacology · 5

Development of novel GI-centric prostaglandin E2 receptor type 4 (EP4) agonist prodrugs as treatment for ulcerative colitis and other intestinal inflammatory diseases

2025 · Srinivas Kantham, Hongbing Yu, et al. · Bioorganic & Medicinal Chemistry Letters · 2

Anticancer and Antimicrobial Activity of 1-((5- Substituted-1,3,4 Oxadiazol-2-yl) Methyl)-4- Benzylpiperazines

2010 · Srinivas Kantham, Shyamkumar Immadi, et al. · 2

Author Correction: E-type prostanoid receptor 4 drives resolution of intestinal inflammation by blocking epithelial necroptosis

2025 · Jay V. Patankar, Tanja M. Müller, et al. · Nature Cell Biology

Works count: 11

Citation count: 327

H-index: 6

I10-index: 5